SHANGHAI NOVAMAB BIOPHARMACEUTICALS

Novamab was founded in October 2017. At present, it has more than 90 employees and has built a research and development and production base of more than 7500 square meters and a camel breeding base. Novamab has independently created five core technology platforms: sdAb rapid screening platform, Pichia pastoris based CMC platform, biologcial drug inhalation platform, long-acting sdAb platform and bispecific sdAb platform. Each platform has unique leading technology, which makes it more competitive.The powerful paltform make it possible to rapidly bring the candidates to commercialization. The completion of the 500L GMP workshop for sdAb production using Pichia pastoris fills the industry gap in this field, which is extremely scarce and competitive... Shanghai Novamab Biopharmaceuticals Co., Ltd., located in Zhoupu International Medical Park, Pudong New Area, Shanghai, is a clinical stage biopharmaceutical company dedicated to the development of innovative sdAb drugs.

Also known as: novamab, Shanghai Novamab Biopharmaceuticals Co., Ltd

Primary location: Shanghai